Commentary: Flow Cytometry Quantification of Tumor-infiltrating Lymphocytes to Predict the Survival of Patients with Diffuse Large B-cell Lymphoma

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 May 3

PMID 38698842

Authors

Zhongling Sun

Ran Tan

Huanling Wu

Xiaosheng Fang

Affiliations

Soon will be listed here.

References

Henrique R, Sousa M, Godinho M, Costa I, Barbosa I, Lopes C . Immunophenotyping by flow cytometry of fine needle aspirates in the diagnosis of lymphoproliferative disorders: A retrospective study. J Clin Lab Anal. 1999; 13(5):224-8. PMC: 6807692. View

Wu S, Jin L, Vence L, Radvanyi L . Development and application of 'phosphoflow' as a tool for immunomonitoring. Expert Rev Vaccines. 2010; 9(6):631-43. PMC: 2933839. DOI: 10.1586/erv.10.59. View

Tilsed C, Fisher S, Nowak A, Lake R, Lesterhuis W . Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front Oncol. 2022; 12:960317. PMC: 9372369. DOI: 10.3389/fonc.2022.960317. View

Martinez A, Aymerich M, Castillo M, Colomer D, Bellosillo B, Campo E . Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. Cytometry B Clin Cytom. 2003; 56(1):8-15. DOI: 10.1002/cyto.b.10044. View

Roider T, Seufert J, Uvarovskii A, Frauhammer F, Bordas M, Abedpour N . Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels. Nat Cell Biol. 2020; 22(7):896-906. DOI: 10.1038/s41556-020-0532-x. View

Laumont C, Banville A, Gilardi M, Hollern D, Nelson B . Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev Cancer. 2022; 22(7):414-430. PMC: 9678336. DOI: 10.1038/s41568-022-00466-1. View

Singh A, Courville E . Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry. Clin Lab Med. 2023; 43(3):351-361. DOI: 10.1016/j.cll.2023.04.010. View

Peng D, Kodituwakku A, Le S, Smith S, Qiu M, Earls P . Factors determining whether diffuse large B-cell lymphoma samples are detected by flow cytometry. Int J Lab Hematol. 2023; 45(6):927-934. DOI: 10.1111/ijlh.14158. View

Bertram H, Check I, Milano M . Immunophenotyping large B-cell lymphomas. Flow cytometric pitfalls and pathologic correlation. Am J Clin Pathol. 2001; 116(2):191-203. DOI: 10.1309/BA3U-RMTU-D7UJ-M8DR. View

10.

Verstovsek G, Chakraborty S, Ramzy I, Jorgensen J . Large B-cell lymphomas: fine-needle aspiration plays an important role in initial diagnosis of cases which are falsely negative by flow cytometry. Diagn Cytopathol. 2002; 27(5):282-5. DOI: 10.1002/dc.10192. View

11.

Steen C, Luca B, Esfahani M, Azizi A, Sworder B, Nabet B . The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021; 39(10):1422-1437.e10. PMC: 9205168. DOI: 10.1016/j.ccell.2021.08.011. View

12.

Fridman W, Meylan M, Petitprez F, Sun C, Italiano A, Sautes-Fridman C . B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat Rev Clin Oncol. 2022; 19(7):441-457. DOI: 10.1038/s41571-022-00619-z. View

13.

Mancuso S, Mattana M, Carlisi M, Santoro M, Siragusa S . Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy. Int J Mol Sci. 2022; 23(6). PMC: 8952275. DOI: 10.3390/ijms23063368. View

14.

Chen J, Tan Y, Sun F, Hou L, Zhang C, Ge T . Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer. Genome Biol. 2020; 21(1):152. PMC: 7315523. DOI: 10.1186/s13059-020-02064-6. View

15.

Hume D, Millard S, Pettit A . Macrophage heterogeneity in the single-cell era: facts and artifacts. Blood. 2023; 142(16):1339-1347. DOI: 10.1182/blood.2023020597. View

16.

Toney N, Schlom J, Donahue R . Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors. J Exp Clin Cancer Res. 2023; 42(1):247. PMC: 10517546. DOI: 10.1186/s13046-023-02802-1. View

17.

Thommen D, Schumacher T . T Cell Dysfunction in Cancer. Cancer Cell. 2018; 33(4):547-562. PMC: 7116508. DOI: 10.1016/j.ccell.2018.03.012. View

18.

Lyons Y, Wu S, Overwijk W, Baggerly K, Sood A . Immune cell profiling in cancer: molecular approaches to cell-specific identification. NPJ Precis Oncol. 2018; 1(1):26. PMC: 5871917. DOI: 10.1038/s41698-017-0031-0. View

19.

Ansell S . Fundamentals of immunology for understanding immunotherapy for lymphoma. Hematology Am Soc Hematol Educ Program. 2020; 2020(1):585-589. PMC: 7727535. DOI: 10.1182/hematology.2020002537. View

20.

Giudice V, Serio B, Bertolini A, Mettivier L, DAlto F, Pezzullo L . Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia. Eur J Haematol. 2022; 109(5):483-493. PMC: 9804478. DOI: 10.1111/ejh.13833. View